https://www.avient.com/sites/default/files/2025-05/AVNT Q1 2025 webcast slides_v17.pdf
All Rights Reserved 2025 18 Reconciliation of Non-GAAP financial measures Senior management uses comparisons of adjusted net income attributable to Avient common shareholders and diluted adjusted earnings per share (EPS) attributable to Avient common shareholders, excluding special items, to assess performance and facilitate comparability of results.
Reconciliation to condensed consolidated statements of income Three months ended March 31, 2025 2024 $ Millions EPS (in $) $ Millions EPS (in $) Net (loss) income attributable to Avient common shareholders (20.2) (0.22) 49.4 0.54 Special items, after-tax 75.7 0.82 5.5 0.06 Amortization expense, after-tax 14.5 0.16 14.9 0.16 Adjusted net income / EPS 70.0 0.76 69.8 0.76 Per share amounts may not recalculate from figures present herein due to rounding 11 1 Reconciliation to EBITDA and Adjusted EBITDA Three months ended March 31, 2025 2024 $ Millions $ Millions Net (loss) income – GAAP (19.9) 49.7 Income tax (benefit) expense (6.7) 16.8 Interest expense, net 26.9 26.6 Depreciation & amortization 45.3 44.3 EBITDA 45.6 137.4 Special items, before tax 101.2 6.2 Interest expense included in special items (1.7) - Depreciation & amortization included in special items (0.4) (0.5) Adjusted EBITDA 144.7 143.1 Adjusted EBITDA as a percent of sales 17.5% 17.3% PAGE 1 OF 3 Copyright © .
All Rights Reserved 2025 20 Reconciliation of Non-GAAP financial measures Reconciliation to condensed consolidated statements of income Three months ended March 31, 2023 $ Millions EPS (in $) Net income from continuing operations attributable to Avient common shareholders 20.8 0.23 Special items, after-tax 22.3 0.24 Amortization expense, after-tax 15.1 0.16 Adjusted net income / EPS 58.2 0.63 1 Reconciliation to EBITDA and Adjusted EBITDA Year ended December 31, 2024 $ Millions Net income – GAAP 170.7 Income tax expense 54.1 Interest expense 105.6 Depreciation & amortization 179.7 EBITDA 510.1 Special items, before tax 20.1 Interest expense included in special items (2.3) Depreciation & amortization included in special items (1.5) Adjusted EBITDA 526.4 Adjusted EBITDA as a percent of sales 16.2% PAGE 3 OF 3 Reconciliation to condensed consolidated statements of income Three months ended June 30, 2024 $ Millions EPS (in $) Net income attributable to Avient common shareholders 33.6 0.36 Special items, after-tax 21.8 0.24 Amortization expense, after-tax 14.8 0.16 Adjusted net income / EPS 70.2 0.76 Reconciliation to condensed consolidated statements of income Year ended December 31, 2024 $ Millions EPS (in $) Net (loss) income attributable to Avient common shareholders 169.5 1.84 Special items, after-tax 15.9 0.17 Amortization expense, after-tax 59.5 0.65 Adjusted net income / EPS 244.9 2.66 Per share amounts may not recalculate from figures present herein due to rounding 1 1 1 Q1 2025 Earnings webcast Slide 1 Slide 2: Disclaimer Slide 3: Q1 2025 highlights Slide 4: Q1 2025 organic revenue growth - by region Slide 5: Playbook in current environment Slide 6 Slide 7: Color, Additives & Inks – Q1 2025 performance Slide 8: Specialty Engineered Materials – Q1 2025 performance Slide 9: Global reach with a local touch Slide 10 Slide 11: 2025 financial guidance unchanged...
https://www.avient.com/knowledge-base/article/overmolding-processing?rtype[]=1164
In order to maximize drying efficiency and achieve high quality parts, desiccant or vacuum dryers are strongly recommended.
In order to reduce the residence time at high temperature, reduce the temperatures in the rear of the injection unit as much as possible and only keep the last zone and nozzle at the high processing temperature.
SEBS formulations release from cool surfaces more easily than hot surfaces.
https://www.avient.com/knowledge-base/article/overmolding-processing
In order to maximize drying efficiency and achieve high quality parts, desiccant or vacuum dryers are strongly recommended.
In order to reduce the residence time at high temperature, reduce the temperatures in the rear of the injection unit as much as possible and only keep the last zone and nozzle at the high processing temperature.
SEBS formulations release from cool surfaces more easily than hot surfaces.
https://www.avient.com/sites/default/files/2020-07/avient-abac-english-200720.pdf
Associates should never offer or accept anything HOME | TOC 3 of value to/from existing or potential customers, suppliers or other third parties in order to improperly obtain business or an unfair advantage for Avient.
Special care must be exercised when transactions may involve payments to government officials.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520KeyBanc%2520Conference%2520-%2520September%252014%25202016.pdf
In addition, operating income before special items and adjusted EPS are components of various PolyOne annual and long-term employee incentive plans. A reconciliation of each non-GAAP financial measure with the most directly comparable GAAP financial measure is attached to this presentation which is posted p p p on our website at www.polyone.com.
Senior management uses operating income excluding special items, adjusted EPS and working capital to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and that current levels may serve as a base for future performance.
Adjusted EPS is calculated as follows: Adjusted EPS 2006Y* 2007Y* 2008Y* 2009Y* 2010Y 2011Y 2012Y 2013Y 2014Y 2015Y Net income (loss) attributable to PolyOne common shareholders $ 130.9 $ 40.9 $ (417.0) $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 $ 144.6 Joint venture equity earnings, after tax (68.5) (26.1) (20.8) (19.0) (14.7) (3.7) — — — — Special items, after tax(1) (51.2) 10.7 457.2 (75.9) (72.5) (72.8) 36.2 32.6 90.5 28.9 Adjusted net income $ 11.2 $ 25.5 $ 19.4 $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 $ 173.5 Diluted shares 92.8 93.1 92.7 93.4 96.0 94.3 89.8 96.5 93.5 88.7 Adjusted EPS $ 0.12 $ 0.27 $ 0.21 $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 $ 1.96 Adjusted EPS Q1 2009* Q2 2009* Q3 2009* Q4 2009* Q1 2010 Q2 2010 Q3 2010 Q4 2010 Net income attributable to PolyOne common shareholders $ 3.3 $ 1.3 $ 51.3 $ 50.8 $ 20.1 $ 44.7 $ 0.1 $ 87.6 Joint venture equity earnings, after tax (8.2) (5.8) (3.0) (2.0) (0.5) (4.5) (6.2) (3.5) Special items, after tax(1) (10.2) 9.2 (36.9) (38.0) (3.8) (22.1) 25.4 (72.0) Adjusted net (loss) income $ (15.1) $ 4.7 $ 11.4 $ 10.8 $ 15.8 $ 18.1 $ 19.3 $ 12.1 Diluted shares 92.2 93.5 93.9 94.4 95.3 96.3 96.3 97.4 Adjusted EPS $ (0.16) $ 0.05 $ 0.12 $ 0.11 $ 0.17 $ 0.19 $ 0.20 $ 0.12 Adjusted EPS Q1 2011 Q2 2011 Q3 2011 Q4 2011 Q1 2012 Q2 2012 Q3 2012 Q4 2012 Net income attributable to PolyOne common shareholders $ 106.0 $ 23.1 $ 16.0 $ 8.3 $ 15.3 $ 18.4 $ 19.4 $ 0.2 Joint venture equity earnings, after tax (3.7) - - - - - - - Special items, after tax(1) (81.3) 1.3 2.8 4.4 6.2 8.9 5.4 15.7 Adjusted net income $ 21.0 $ 24.4 $ 18.8 $ 12.7 $ 21.5 $ 27.3 $ 24.8 $ 15.9 Diluted shares 96.4 95.5 94.0 91.9 90.7 90.7 90.2 90.5 Adjusted EPS $ 0.22 $ 0.26 $ 0.20 $ 0.14 $ 0.24 $ 0.30 $ 0.28 $ 0.18 2 Adjusted EPS Q1 2013 Q2 2013 Q3 2013 Q4 2013 Q1 2014 Q2 2014 Q3 2014 Q4 2014 Net income (loss) attributable to PolyOne common shareholders $ 11.2 $ 38.6 $ 23.2 $ 21.0 $ 29.4 $ 30.9 $ 32.3 $ (14.6) Special items, after tax(1) 17.7 (2.0) 12.3 4.6 12.5 17.4 13.1 47.5 Adjusted net income $ 28.9 $ 36.6 $ 35.5 $ 25.6 $ 41.9 $ 48.3 $ 45.4 $ 32.9 Diluted shares 92.8 99.1 98.1 97.2 95.7 94.3 93.1 91.3 Adjusted EPS $ 0.31 $ 0.37 $ 0.36 $ 0.26 $ 0.44 $ 0.51 $ 0.49 $ 0.36 Adjusted EPS Q1 2015 Q2 2015 Q3 2015 Q4 2015 Q1 2016 Q2 2016 Net income attributable to PolyOne common shareholders $ 30.2 $ 66.8 $ 44.5 $ 3.1 $ 39.1 $ 50.0 Special items, after tax(1) 11.4 (15.9) 3.0 30.4 9.1 3.2 Adjusted net income $ 41.6 $ 50.9 $ 47.5 $ 33.5 $ 48.2 $ 53.2 Diluted shares 90.1 89.8 88.4 86.6 85.5 84.7 Adjusted EPS $ 0.46 $ 0.57 $ 0.54 $ 0.39 $ 0.56 $ 0.63 Adjusted operating margin is calculated as follows: Adjusted operating margin Q1 2009* Q2 2009* Q3 2009* Q4 2009* YTD 2009* Q1 2010 Q2 2010 Q3 2010 Q4 2010 YTD 2010 Operating Income $ 9.9 $ 17.1 $ 57.9 $ 52.2 $ 137.1 $ 32.3 $ 58.6 $ 42.0 $ 26.3 $ 159.2 Special items (1) (1.3) 4.6 (27.5) (24.5) (48.7) - (14.5) 5.5 4.2 (4.8) Joint venture equity earnings (12.8) (9.0) (4.8) (3.1) (29.7) (0.8) (7.1) (9.7) (5.5) (23.1) Adjusted operating (loss) income $ (4.2) $ 12.7 $ 25.6 $ 24.6 $ 58.7 $ 31.5 $ 37.0 $ 37.8 $ 25.0 $ 131.3 Sales $ 463.4 $ 496.5 $ 548.3 $ 552.5 $ 2,060.7 $ 604.0 $ 666.2 $ 650.7 $ 585.3 $ 2,506.2 Operating Margin (0.9)% 2.6% 4.7% 4.5% 2.8% 5.2% 5.6% 5.8% 4.3% 5.2% Adjusted operating margin Q1 2011 Q2 2011 Q3 2011 Q4 2011 YTD 2011 Q1 2012 Q2 2012 Q3 2012 Q4 2012 YTD 2012 Operating income (loss) $ 173.4 $ 42.4 $ 33.4 $ (46.2) $ 203.0 $ 37.4 $ 43.3 $ 43.5 $ 13.3 $ 137.5 Special items (1) (127.2) 2.7 4.9 72.9 (46.7) 8.5 11.8 8.3 25.3 53.9 Joint venture equity earnings (5.7) - - - (5.7) - - - - - Adjusted operating income $ 40.5 $ 45.1 $ 38.3 $ 26.7 $ 150.6 $ 45.9 $ 55.1 $ 51.8 $ 38.6 $ 191.4 Sales $ 682.8 $ 723.4 $ 694.0 $ 609.2 $ 2,709.4 $ 745.5 $ 756.6 $ 707.7 $ 651.0 $ 2,860.8 Operating Margin 5.9% 6.2% 5.5% 4.4% 5.6% 6.2% 7.3% 7.3% 5.9% 6.7% 3 Adjusted operating margin Q1 2013 Q2 2013 Q3 2013 Q4 2013 YTD 2013 Q1 2014 Q2 2014 Q3 2014 Q4 2014 YTD 2014 Operating income (loss) $ 40.5 $ 80.7 $ 61.6 $ 48.7 $ 231.5 $ 56.4 $ 49.4 $ 63.6 $ (14.3) $ 155.1 Special items (1) 16.6 (5.2) 10.8 7.8 30.0 22.9 39.8 22.0 80.2 164.9 Adjusted operating income $ 57.1 $ 75.5 $ 72.4 $ 56.5 $ 261.5 $ 79.3 $ 89.2 $ 85.6 $ 65.9 $ 320.0 Sales $ 801.1 $ 1,037.6 $ 1,008.9 $ 923.6 $ 3,771.2 $ 1,002.3 $ 1,005.5 $ 958.4 $ 869.3 $ 3,835.5 Operating Margin 7.1% 7.3% 7.2% 6.1% 6.9% 7.9% 8.9% 8.9% 7.6% 8.3% Adjusted operating margin Q1 2015 Q2 2015 Q3 2015 Q4 2015 YTD 2015 Q1 2016 Q2 2016 Operating income $ 70.1 $ 80.3 $ 69.2 $ 31.3 $ 250.9 $ 71.3 $ 81.5 Special items (1) 9.3 11.9 18.7 31.4 71.3 13.8 10.4 Adjusted operating income $ 79.4 $ 92.2 $ 87.9 $ 62.7 $ 322.2 $ 85.1 $ 91.9 Sales $ 873.1 $ 887.1 $ 841.6 $ 775.8 $ 3,377.6 $ 847.0 $ 861.5 Operating Margin 9.1% 10.4% 10.4% 8.1% 9.5% 10.0% 10.7% Adjusted gross margin is calculated as follows: (In millions) Twelve Months Ended December 31, 2015 Gross margin - GAAP $ 681.5 Special items in gross margin(1) 39.7 Gross margin before special items $ 721.2 Specialty platform percentage of operating income is calculated as follows: Platform operating income mix percentage 2006Y* Q2 2016 Color, Additives and Inks $ 8.9 $ 38.2 Specialty Engineered Materials 3.9 21.4 Designed Structures and Solutions — 1.0 Specialty Platform $ 12.8 $ 60.6 Performance Products and Solutions 64.2 21.3 Distribution 19.2 17.8 Joint ventures 102.9 — Corporate and eliminations 34.5 (18.2) Operating income GAAP $ 233.6 $ 81.5 Less: Corporate and eliminations (34.5) 18.2 Operating income excluding Corporate $ 199.1 $ 99.7 Specialty platform percentage of operating income excluding corporate 6% 61% 4 Adjusted EBITDA and net debt to adjusted EBITDA is calculated as follows: (In millions) Six Months Ended June 30, 2015 Twelve Months Ended December 31, 2015 Six Months Ended June 30, 2016 Trailing Twelve Months Ended June 30, 2016 Income from continuing operations, before income taxes $ 116.7 $ 167.7 $ 123.6 $ 174.6 Interest expense, net 32.3 64.1 29.2 61.0 Depreciation and amortization 50.1 104.3 52.4 106.6 Special items, impact on income (loss) from continuing operations before income taxes(1) 21.2 87.6 24.5 90.9 Accelerated depreciation included in special items (0.3) (6.2) (3.2) (9.1) Adjusted EBITDA(2) $ 220.0 $ 417.5 $ 226.5 $ 424.0 Short-term and current portion of long-term debt $ 18.4 Long-term debt 1,126.2 Total Debt 1,144.6 Less: Cash and cash equivalents (161.4) Net Debt $ 983.2 Net Debt / TTM Adjusted EBITDA 2.3 * Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principal, discontinued operations or the related resegmentation. (1) Special items are a non-GAAP financial measure and are used to determine adjusted earnings.
https://www.avient.com/sites/default/files/2023-01/GeorgeInglis.pdf
GEORGE INGLIS Vice President, Corporate Controller George Inglis is Vice President, Corporate Controller of Avient Corporation, a premier provider of specialized and sustainable material solutions and services.
Inglis has taken on numerous special assignments in his tenure, including supporting Avient’s speciality transformation through M&A activity as well as establishing Avient’s Global Business Services (GBS).
https://www.avient.com/industries/healthcare/medical-devices-equipment/surgical-medical-instruments
Colorant Chromatics™ Evoluscend™ Non-PFAS High-Temperature Mold Release Additive
Learn about additives are specially formulated to meet material performance requirements in today’s healthcare environments
https://www.avient.com/knowledge-base/article/whats-difference-tpes-vs-silicones
Like LSR, TPEs offer you the chance to achieve a wide variety of colors and special effects with relative ease.
They also require precise venting and vacuum to release off-gassing during the chemical curing process and must withstand temperatures more than twice that of TPE molds (170°F vs. 320-420°F)
Keep in mind that a limited number of toolmakers specialize in LSR molds—and many are based in Europe.
https://www.avient.com/knowledge-base/article/whats-difference-tpes-vs-silicones?ind[]=21537
Like LSR, TPEs offer you the chance to achieve a wide variety of colors and special effects with relative ease.
They also require precise venting and vacuum to release off-gassing during the chemical curing process and must withstand temperatures more than twice that of TPE molds (170°F vs. 320-420°F)
Keep in mind that a limited number of toolmakers specialize in LSR molds—and many are based in Europe.
https://www.avient.com/sites/default/files/2020-08/avient-investor-presentation-jefferies-industrials-conference.pdf
Reconciliation to Adjusted EPS Excluding Special Items and Impacts of February 2020 Equity Offering Three Months Ended March 31, 2020 Net income from continuing operations – GAAP $ 33.1 Special items, after tax (1) 8.6 After tax interest income earned on equity proceeds, included in Interest expense, net (0.7) Adjusted net income excluding special items and impact of interest income on equity proceeds $ 41.0 Diluted weighted-average shares used to compute earnings per common share 86.7 Weighted-average impact of 15.3 million shares issued in February 2020 equity offering (9.3) Diluted weighted-average shares excluding impact of shares issued in February 2020 equity offering 77.4 Adjusted EPS - excluding special items and the net impact of equity offering $ 0.53 Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to PolyOne shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to PolyOne shareholders, excluding special items, to assess performance and facilitate comparability of results.
Avient Corporation 33 Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.
Reconciliation to Adjusted EPS Excluding Special Items and Impacts of February 2020 Equity Offering and May 2020 Debt Offering Three Months Ended June 30, 2020 Net income from continuing operations attributable to Avient common shareholders $ 23.0 Special items, after tax(1) 2.6 After tax interest expense, net arising from equity offering and debt offering proceeds 4.1 Adjusted net income excluding special items and impact of interest expense, net arising from equity offering and debt offering proceeds $ 29.7 Diluted weighted-average shares used to compute earnings per common share 91.8 Weighted-average impact of 15.3 million shares issued in February 2020 equity offering (15.3) Diluted weighted-average shares excluding impact of shares issued in February 2020 equity offering 76.5 Adjusted EPS excluding special items and impact of equity offering and debt offering $ 0.39 (1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures, including adjustments related to contingent consideration; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to-market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non- recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results.